Results

Total Results: 3,981 records

Showing results for "cardiovascular".
Users also searched for: statin

341. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
     January 01, 2007 - Cardiovascular mortality and morbidity. … Linking these effects to cardiovascular outcomes will also help clarify the clinical relevance. … Rosiglitazone evaluated for cardiovascular outcomes–an interim analysis. N Engl J Med 2007. … Cardiovascular Low to very low It was unclear whether cardiovascular mortality differed when disease … cardiovascular morbidity differed between the medications. 2d.

342. 4Nuuvs6Nmztdbgjbg3Elke (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/4NUuvS6nmzTdBgjBg3ELkE
     January 01, 2020 - Behavioral Counseling to Promote a Healthy Lifestyle in Persons With Cardiovascular Risk Factors: A Systematic … A substantial portion of the U.S. population has at least one modifiable risk factor for cardiovascular … We included studies in adults who had at least 1 cardiovascular risk factor, including hypertension, … with Cardiovascular Risk Factors: An Updated Systematic Review for the U.S. … Cardiovascular effects of intensive lifestyle interven- tion in type 2 diabetes.

343. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2002 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
     January 15, 2002 - to Email Print archived Evidence Summary Aspirin Use to Prevent Cardiovascular … We identified five trials that examined the effect of aspirin on cardiovascular events in patients with … The net benefit of aspirin increases with increasing cardiovascular risk. … events averted when the cardiovascular event rate was 0.22 percent per year. … Aspirin for the primary prevention of cardiovascular events: summary of the evidence.

344. Design and Testing of a Mobile Cardiovascular Risk Service with Patient Partners - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/r21hs023952-chrischilles-final-report-2018.pdf
     January 01, 2018 - Design and Testing of a Mobile Cardiovascular Risk Service with Patient Partners - Final Report 1 … Design and Testing of a Mobile Cardiovascular Risk Service with Patient Partners Final Report … risk service (CVRS) for improving cardiovascular disease (CVD) management. … Ineffective secondary prevention in survivors of cardiovascular events in the US population: report … The implications of therapeutic complexity on adherence to cardiovascular medications.

345. Screening for Hypertension in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/QaNSteuunshjz-kHPxVvAN
     April 27, 2021 - Eligible health outcomes were all-cause and cardiovascular mortality, cardiovascular disease events, … Dietary advice for reducing cardiovascular risk. … Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular … White-coat hypertension and cardiovascular events: a meta-analysis. … White-coat hypertension is a risk factor for cardiovascular diseases and total mortality.

346. | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/publications/search.html?page=6
     August 01, 2017 - Publication Number: A1517-EHC027-A EHC Clinician Guide - Omega - 3 Fatty Acids and Cardiovascular … of omega-3 fatty acids, primarily from marine oil supplements, on clinical and selected intermediate cardiovascular … lipid concentrations) and the association of omega-3 fatty acids dietary intake and biomarkers with cardiovascular

347. Archived: Final Research Plan: Aspirin to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     October 07, 2013 - archived Final Research Plan: Aspirin to Prevent Cancer Aspirin Use to Prevent Cardiovascular … who are not contraindicated for regular aspirin use for the primary prevention of colorectal cancer, cardiovascular … continued regular use in persons who initiate aspirin use for the prevention of colorectal cancer, cardiovascular … disease (secondary prevention of cardiovascular disease for sensitivity analyses) Secondary or … and aligns this Research Plan with the companion Research Plan on aspirin use for the prevention of cardiovascular

348. Self Management & Reminders with Technology: SMART Appraisal of an Integrated PHR - 2010 | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/self-management-reminders-technology-smart-appraisal-integrated-phr/annual-summary/2010
     January 01, 2010 - project seeks to improve health care outcomes in patients who have or are at high risk for developing cardiovascular … enrollment for the trial has been set at 1,200 patients with complex chronic disease leading to increased cardiovascular … help determine if the use of an active patient self-management version of an existing PHR can reduce cardiovascular … electronic PHR for patients with complex illnesses and conditions that contribute to the development of cardiovascular … and text alerts are being transmitted to the patients in the intervention group based on the specific cardiovascular

349. Final Research Plan: Abdominal Aortic Aneurysm: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/abdominal-aortic-aneurysm-screening
     November 30, 2017 - disease mortality, aneurysm rupture rate, cardiovascular disease events, and quality of life KQ … false-positive results KQ 4: AAA annual growth rate, all-cause mortality, aneurysm-related mortality, cardiovascular … disease mortality, aneurysm rupture rate, cardiovascular disease events, and quality of life KQ 5: … In response to comments, the USPSTF expanded the scope of the evidence review to include cardiovascular … events (e.g., myocardial infarction, stroke) and mortality related to cardiovascular disease to more

350. EvidenceNOW: Oklahoma Cooperative | Agency for Healthcare Research and Quality
     www.ahrq.gov/evidencenow/projects/heart-health/about/cooperatives/oklahoma.html
     March 01, 2021 - that primary care practices have the evidence they need to help their patients adopt  the ABCS of cardiovascular … and 9.8 percent is Hispanic. 1 Oklahoma's health statistics are among the worst in the Nation, with cardiovascular … Hearts for Oklahoma, 2017] The Effect of Quality Improvement Orientation and Organizational Change on Cardiovascular … GREAT) Symposium, 2017] The Effect of Quality Improvement Orientation and Organizational Change on Cardiovascular … Duffy, (2) Assessing Misclassification Error on Estimated Cardiovascular Care Performance by Juell Homco

351. JAMA JATS (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Nop5YpEpMybx_oNPKC76-X
     July 11, 2017 - JAMA JATS Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular … All persons, regardless of their risk status for cardiovascular disease (CVD), can gain health benefits … CVD indicates cardiovascular disease; USPSTF, US Preventive Services Task Force. … in adults with cardiovascular risk factors: U.S. … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S.

352. Section 1, Tables 1 to 3 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-section-1-tables-1-3.pdf
     June 02, 2025 - Severe Sepsis and Septic Shock Term Definition Severe sepsis Sepsis plus one of the following: cardiovascular … infection” OR • “Rule out sepsis” OR • “Suspected sepsis” Term Definition Organ dysfunctions Cardiovascular … applicable for newborn) OR • ALT 2 times upper limit of normal for age Septic Shock Sepsis and cardiovascular

353. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/866355/psn-pdf
     July 24, 2024 - Most ADEs involved cardiovascular, central nervous system, or anti-infective medications. … hospitalizations-and-deaths-related-adverse-drug-events-worldwide-systematic-review-studies https://psnet.ahrq.gov/issue/patient-harm-cardiovascular-medications

354. Bonnevie L et al. 2005 "The use of computerized decision support systems in preventive cardiology-principal results from the national PRECARD survey in Denmark." | Digital Healthcare Research
     digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/bonnevie-l-et-al-2005
     January 01, 2005 - Abstract "Background: The [risk management tool] program has been used for electronic cardiovascular … Objective To report the use of and attitudes toward an electronic risk management tool on cardiovascular … myocardial infarction, stroke or any fatal event in patients under the age of 70 and without existing [cardiovascular

355. Ykjvkfmv5Jf8Bl3Rbx8Bp7 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ykjVKfmV5Jf8bL3rBx8BP7
     December 01, 2015 - Recommendation: The USPSTF recommends screening for ab- normal blood glucose as part of cardiovascular … RATIONALE Importance Cardiovascular disease (CVD) is the leading cause of death in the United States … Neither study had follow-up beyond 10 years or measured non- fatal cardiovascular events. … Effect of nateglinide on the incidence of diabetes and cardiovascular events. … Effect of valsartan on the incidence of diabetes and cardiovascular events.

356. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
     March 01, 2011 - In addition, the death rate from cardiovascular disease in adults with type 2 diabetes is two to four … Cardiovascular mortality 3. … Cardiovascular and cerebrovascular morbidity (e.g., myocardial infarction and stroke) 4. … Metformin was associated with slightly lower all-cause mortality and cardiovascular disease mortality … (continued) Cardiovascular and Low A comparison of the risk of cardiovascular morbidity between metformin

357. Archived: High Blood Pressure in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-blood-pressure-in-adults-screening-monitoring-october-2015
     October 12, 2015 - White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. … Cardiovascular risk in white-coat and sustained hypertensive patients. … Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular … Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation. … CV = cardiovascular; HF = heart failure; HR = hazard ratio; MI = myocardial infarction.

358. 154. Treatment Recommendations: Medications-Nortriptyline | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide154.html
     October 01, 2014 - Cardiovascular and other effects —Because of the risk of arrhythmias and impairment of myocardial contractility … , use with caution in patients with cardiovascular disease.

359. CER 244 Evidence Summary: Safety of Vaccines Used for Routine Immunization in the United States: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
     May 01, 2021 - High Dose Quadrivalent®, Fluzone Quadrivalent®) Low: No evidence of increased risk of asthma, cardiovascular … -valent pneumococcal conjugate (PCV13; Prevnar 13®) Moderate: No evidence of increased risk of cardiovascular … valent pneumococcal polysaccharide (PPSV23; Pneumovax®) High: No evidence of increased risk of cardiovascular … increased risk of amyotrophic lateral sclerosis, anaphylaxis or systemic allergic reaction, asthma, cardiovascular … Moderate: No evidence of increased risk of death Low: No evidence of increased risk of asthma, cardiovascular

360. Wake Up Safe. | PSNet
     psnet.ahrq.gov/issue/wake-safe
     April 22, 2020 - April 13, 2011 A theoretical model of flow disruptions for the anesthesia team during cardiovascular … December 10, 2014 FOCUS: The Society of Cardiovascular Anesthesiologists' initiative … to improve quality and safety in the cardiovascular operating room.